Growing the love for investing
Results 1 - 10 of 757 : 1 2 3 4 5 6 7 8 9 Next
These undervalued stocks have strong growth prospects.
These stocks just rolled over. Can they come back?
2 Dow Stocks That Missed the Rally
Not everybody won after the excellent unemployment numbers.
Curing Diseases Makes For a Bad Business Model
Vertex got to a lot of patients quickly, but now what?
Why the Nasdaq's at an 11-Year High Today
A brief look at the tech index's moves so far on Friday.
Idenix Pharmaceuticals Shares Dropped: What You Need to Know
Is this meaningful or just another movement?
Gilead Sciences Shares Surged: What You Need to Know
Is this meaningful or just another movement?
Gilead Sciences Meets on the Top Line, Misses Where it Counts
Just the facts, Fool.
Has Amgen Become the Perfect Stock?
Finding companies that have all the right stuff can produce winners.
Maximum Market: $2.9 Billion, For Now
Vertex gains FDA approval for cystic fibrosis treatment Kalydeco.
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates and Analyst Ratings provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions
RSS Headlines
Fool UK